As of 2026-04-09, the Relative Valuation of Creo Medical Group PLC (CREO.L) is 77.17 GBP. This relative valuation is based on P/E multiples. With the latest stock price at 11.13 GBP, the upside of Creo Medical Group PLC based on Relative Valuation is 593.7%.
The range of the Relative Valuation is 58.94 - 91.87 GBP.
| Range | Selected | |
| Trailing P/E multiples | 17.8x - 25.0x | 23.8x |
| Forward P/E multiples | 16.0x - 18.4x | 18.2x |
| Fair Price | 58.94 - 91.87 | 77.17 |
| Upside | 429.8% - 725.8% | 593.7% |
| Date | P/E |
| 2026-04-08 | 3.04 |
| 2026-04-07 | 2.97 |
| 2026-04-02 | 2.97 |
| 2026-04-01 | 2.97 |
| 2026-03-31 | 2.84 |
| 2026-03-30 | 3.14 |
| 2026-03-27 | 3.25 |
| 2026-03-26 | 3.31 |
| 2026-03-25 | 3.31 |
| 2026-03-24 | 3.31 |
| 2026-03-23 | 3.31 |
| 2026-03-20 | 3.22 |
| 2026-03-19 | 3.31 |
| 2026-03-18 | 3.65 |
| 2026-03-17 | 3.72 |
| 2026-03-16 | 3.65 |
| 2026-03-13 | 3.76 |
| 2026-03-12 | 3.85 |
| 2026-03-11 | 3.85 |
| 2026-03-10 | 3.86 |
| 2026-03-09 | 3.76 |
| 2026-03-06 | 3.76 |
| 2026-03-05 | 3.88 |
| 2026-03-04 | 3.85 |
| 2026-03-03 | 3.82 |
| 2026-03-02 | 4.03 |
| 2026-02-27 | 4.14 |
| 2026-02-26 | 4.12 |
| 2026-02-25 | 4.31 |
| 2026-02-24 | 4.50 |
| 2026-02-23 | 4.44 |
| 2026-02-20 | 4.51 |
| 2026-02-19 | 4.50 |
| 2026-02-18 | 4.53 |
| 2026-02-17 | 4.68 |
| 2026-02-16 | 4.57 |
| 2026-02-13 | 4.58 |
| 2026-02-12 | 4.56 |
| 2026-02-11 | 4.67 |
| 2026-02-10 | 4.77 |
| 2026-02-09 | 4.80 |
| 2026-02-06 | 4.85 |
| 2026-02-05 | 4.77 |
| 2026-02-04 | 4.67 |
| 2026-02-03 | 3.79 |
| 2026-02-02 | 3.89 |
| 2026-01-30 | 3.93 |
| 2026-01-29 | 4.10 |
| 2026-01-28 | 3.85 |
| 2026-01-27 | 3.45 |